Terry Smith - Fundsmith Holdings – 2025 Q4
Explore the latest portfolio disclosure for Terry Smith - Fundsmith, with insights into sector exposure, position sizes, and overall investment structure for 2025 Q4.
The latest 2025 Q4 filing shows that Terry Smith - Fundsmith maintains its largest exposure in Healthcare, which represents approximately 30.51% of the portfolio. This sector forms the core of Terry Smith - Fundsmith's investment stance during this reporting period.
Additional major allocations include Technology (about 26.53%) and Consumer Defensive (approximately 12.97%) , reflecting how Terry Smith - Fundsmith diversifies beyond its primary sector focus.
These sector weightings provide a clear view into Terry Smith - Fundsmith's positioning and conviction areas for the 2025 Q4 quarter.
Breakdown by Sector
| Symbol | Shares | Reported Price(USD) | Action | Change % | Portfolio Weight | Position Value | Filing Period |
|---|---|---|---|---|---|---|---|
| NSSC | 1,779,857 | $41.7 | No Change | No Change | 0.43% | $74.22M | 2025 Q4 |
| DOCS | 1,650,002 | $44.28 | Increased | 21.69% | 0.43% | $73.06M | 2025 Q4 |
| NTNX | 1,377,158 | $51.69 | Buy | 100.00% | 0.42% | $71.19M | 2025 Q4 |
| VRT | 410,944 | $162.01 | Reduced | -30.52% | 0.39% | $66.58M | 2025 Q4 |
| VRSN | 270,634 | $242.95 | No Change | No Change | 0.38% | $65.75M | 2025 Q4 |
| CLX | 613,497 | $100.83 | No Change | No Change | 0.36% | $61.86M | 2025 Q4 |
| MANH | 288,332 | $173.31 | No Change | No Change | 0.29% | $49.97M | 2025 Q4 |
| GGG | 579,016 | $81.97 | Reduced | -35.70% | 0.28% | $47.46M | 2025 Q4 |
| MEDP | 82,567 | $561.65 | Reduced | -35.26% | 0.27% | $46.37M | 2025 Q4 |
| ADMA | 2,102,054 | $18.24 | Buy | 100.00% | 0.22% | $38.34M | 2025 Q4 |
| SABR | 21,499,095 | $1.36 | No Change | No Change | 0.17% | $29.24M | 2025 Q4 |
| HD | 80,206 | $344.1 | Reduced | -5.48% | 0.16% | $27.6M | 2025 Q4 |